SCHEMBL2184741

SCHEMBL2184741

CN1CCc2[nH]c3ccc(OC(C)(C)C)cc3c2C1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.73
HSD17B10 Q99714 2/20 0.73
USP2 O75604 1/20 0.73
CYP1A2 P05177 1/20 0.73
CYP2D6 P10635 1/20 0.73
CYP2C9 P11712 1/20 0.73
L3MBTL1 Q9Y468 1/20 0.62
CHRNA7 P36544 1/20 0.57
SIRT2 Q8IXJ6 1/20 0.55
HTR6 P50406 5/20 0.54
POLB P06746 2/20 0.54
KDM4E B2RXH2 1/20 0.54
ALDH1A1 P00352 1/20 0.54
MAPK1 P28482 1/20 0.54
GAA P10253 1/20 0.53
BAZ2B Q9UIF8 1/20 0.51
DRD2 P14416 1/20 0.50
DRD1 P21728 1/20 0.50
DRD5 P21918 1/20 0.50
DRD3 P35462 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2187386 0.89 ALOX15 (0.71) ALOX15HSD17B10USP2CYP1A2CYP2D6
SCHEMBL168545 0.85 ALOX15 (0.97) ALOX15HSD17B10USP2CYP1A2CYP2D6
SCHEMBL2190311 0.80 L3MBTL1 (0.67) ALOX15HSD17B10USP2CYP1A2CYP2D6
Dehydrostobadine SCHEMBL167500 0.78 L3MBTL1 (0.97) ALOX15HSD17B10USP2CYP1A2CYP2D6
Dehydrostobadine SCHEMBL29468212 0.78 L3MBTL1 (0.97) ALOX15HSD17B10USP2CYP1A2CYP2D6
SCHEMBL12479812 0.78 L3MBTL1 (0.64) ALOX15HSD17B10USP2CYP1A2CYP2D6
SCHEMBL19252850 0.77 L3MBTL1 (0.70) ALOX15HSD17B10USP2CYP1A2CYP2D6
SCHEMBL2186097 0.77 L3MBTL1 (0.70) ALOX15HSD17B10USP2CYP1A2CYP2D6
SCHEMBL407913 0.77 L3MBTL1 (0.70) ALOX15HSD17B10USP2CYP1A2CYP2D6
SCHEMBL167328 0.77 L3MBTL1 (0.70) ALOX15HSD17B10USP2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458155-B2 Pyrido[4,3-b]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC (US) 2016-10-04 US disclosed
US-20150051218-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. 2015-02-19 US disclosed
US-8907097-B2 Pyrido[4,3-b]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC. (US) 2014-12-09 US disclosed
US-8906925-B2 Pyrido[4,3-B]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC. (US) 2014-12-09 US disclosed
US-20130190322-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. (US) 2013-07-25 US disclosed
EP-2346332-A1 PYRIDO (4,3-B) INDOLES CONTAINING RIGID MOIETIES Medivation Technologies, Inc. (US) 2011-07-27 EP disclosed
US-20100216814-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. 2010-08-26 US disclosed
WO-2010051501-A1 PYRIDO (4,3-B) INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. (US) 2010-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150051218-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES HTR3B, HTR3D, HTR3A ALOX15 788/4885HSD17B10 2484/4885USP2 3980/4885
US-20130190322-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES HTR3B, HTR3D, HTR3A ALOX15 788/4885HSD17B10 2484/4885USP2 3980/4885
US-20100216814-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES HTR3B, HTR3D, HTR3A ALOX15 788/4885HSD17B10 2484/4885USP2 3980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.